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Abstract 
Hepatitis C virus (HCV) infection is a global problem due to the difficulties in developing a 
protective vaccine. In this work, we demonstrated that the ethyl acetate extract of the endophytic fungus 
Aspergillus versicolor exhibited significant activity against HCV NS3-NS4A protease with IC50 value 
of 30 µg/ml. The fungus was isolated from the black sponge Spongia officinalis and identified by its 
morphology and 18S rDNA. Large-scale fermentation of the fungus followed by chromatographic 
purification of the active extract from the liquid medium allowed the isolation of known metabolites 
related to cyclodipeptides or the so called diketopiperazines (DKPs). The diketopiperazine, cyclo(L-
Tyr-L-Pro) displayed strong inhibitory effect as anti-HCV protease with IC50 value of 8.2 µg/ml. A 
computational docking study of the isolated cyclo(L-Tyr-L-Pro) against HCV protease was used to 
formulate a hypothetical mechanism for the inhibitory activity of the active compound on the tested 
enzyme. 
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Introduction 
Hepatitis C virus (HCV) infection is a major cause of human liver disease throughout the world, leading 
to cirrhosis, carcinoma and liver failure [1]. Recently, HCV NS3/4A protease inhibitors have emerged 
as a promising potential treatment for HCV infection [2]. Unlike interferons, which work by stimulating 
the immune system’s response to viral infection, NS3 protease inhibitors target the virus directly by 
inhibiting NS3/4A serine protease, a key enzyme involved in HCV replication [3].  
In recent years, numerous metabolites possessing uncommon structures and potent bioactivities 
have been isolated from strains of fungi collected from diverse environments, such as soils, animals, 
plants, and sediments [4]. As ubiquitous fungus Aspergillus versicolor has been ascertained to afford 
excellent biologically active products, such as sesqueterpenoids [5,6], diterpenes [7], cyclopeptides [8], 
diketopiperazines [9], anthraquinone [10], isocoumarins [11], alkaloids [12,13] and diphenyl ethers 
[14,15]. Many of these metabolites produced by A. versicolor exhibit antioxidants, cytotoxic properties, 
antibacterial, fungicidal, insecticidal, and lipid lowering effects [16-21]. 
Motivated by a search for new bioactive metabolites from the fermentation products of 
endophytic fungi, A. versicolor was isolated from the inner tissues of the Red Sea black sponge Spongia 
officinalis. This paper deals with the isolation and structure elucidation of eight secondary metabolites, 
their antimicrobial activity, and their inhibitory effect on HCV NS3-NS4A protease using a SensoLyte 
TM 520 HCV protease assay kit.  
 
Materials and Methods 
General Experimental Procedures  
Optical rotations were measured in methanol on a Perkin-Elmer 241 instrument at the sodium D line 
(589 nm). The UV spectra were acquired in methanol using Thermo Scientific NanoDrop 2000C UV-
Vis spectrophotometer. IR spectra were measured using JASCOFT/IR-300E spectrophotometer. 1H and 
13C NMR spectra were recorded at 25°C with a Varian Inova-NMR 600 MHz NMR spectrometer. High-
resolution mass spectra were acquired with a Thermo scientific LTQ/XL Orbitrap, specifications; 
analyzer: FTMS, mass range: normal full ms 100-2000, resolution: 30,000. HPLC was performed on 
Agilent 1260 Infinity preparative HPLC system with an Agilent Eclipse XDB-C18 column (5µ, 10 x 
250 mm, Agilent technologies, USA). All chemical reagents were purchased from Sigma-Aldrich and 
used without further purification. 
 Enzymes and chemicals 
The SensolyteTM 520 HCV protease assay kit Fluorimetric (Lot# AK71145-1020), HCV NS3-NS4A 
protease, HCV NS3- NS4A protease inhibitor 2 (cat# 25346), and SensolyteTM Green protease assay 
kit Fluorimetric (Lot# AK71124-1011) were purchased from AnaSpec (San Jose, CA, USA). Soybean 
trypsin-chymotrypsin inhibitor was purchased from Sigma Aldrich (St. Louis, MO, USA). Falcon TM 
Microtest TM 384-well 120 µl black assay plates, non-sterile, no lid, were purchased from Becton 
Dickinson (Tokyo, Japan).  
 
Fungal isolation and culture conditions 
The black sponge Spongia officinalis was collected from the Egyptian Red Sea at a depth of 20 m off 
the coast of Rass Mohamed (South Sinai, Egypt) in March 2010. The sample was selected solely on the 
basis of a clean and healthy exterior, and brought to the laboratory in ice. In the laboratory, specimens 
were washed with sterile water and processed immediately. The sample was identified by the Coral 
Reef Ecology and Biology Group, National Institute of Oceanography and Fisheries, Suez, Egypt. 
After proper washing, samples were cut into 0.5- to 1-cm pieces, surface-sterilized with 70% 
ethanol for 1 min, and rinsed three times with sterile distilled water. The algal pieces were blotted on 
sterile blotting paper. Each piece was placed in a Petri dish on the surface of solid potato dextrose agar 
(PDA) medium containing (g/l) potato (200), glucose (10), and agar (15) at pH 7.5 prepared in 50% sea 
water supplemented with penicillin benzyl sodium salt (0.02 g/l) to avoid any bacterial growth.  
 
Morphological and molecular identification of the endophytic isolate  
After 10 days of incubation in (PDA) medium, white colonies were developed and changed to green. It 
is characterized by biseriate aspergilla and conidia in shade of green. These morphological features are 
typically Aspergillus versicolor colonies. 18S rRNA (Ribonucleic acid) sequencing technique was 
employed to identify the fungal isolates on a molecular level. The universal primers 18SF149:5'-
GGAAGGG(G/A)TGTATTATTAG  3'and 18SR 701: 5'-GTAAAAGTCCTGGTTCCC-3', were used 
to amplify a partial fragment (522bp) of the 18SrRNA from fungal strain isolate PCR. The PCR mixture 
contained 25 pmol of each primer, 10 ng of chromosomal DNA, 200 mM dNTPs and 2.5 U of Taq 
polymerase in 50 µl of polymerase buffer. The PCR thermocycler (Eppendorf) was programmed as 
follow: 95°C for 5 min for initial denaturation, 30 cycles 95°C for 1 min, 55°C for 1 min and 72°C for 
2 min. and a final extension of at 72°C for 10 min. Five microliters of the obtained PCR product were 
analyzed on 1% agarose gel electrophoresis [13] and were visualized on UV transilluminator. The PCR 
product was purified using QIAquick PCR purification reagent (Qiagen). The amplified 18S rRNA 
fragment (552 bp) was sequenced in both directions. BLAST (www.ncbi.nlm.nih.gov/blast) sequence 
analysis was carried out to affiliate the strain isolate. Multiple sequence alignment and molecular 
phylogeny was performed using BioEdit [21].  
According to sequencing similarities and multiple alignment the fungus was found to be in a close 
relation to Aspergillus versicolor strain F21 CBS 583.65 (gb:JN252119.1) with 97% identity. DNA 
sequencing was carried out by Sequencer (ABI 3730XLs, Macrogen Inc.), Scientific Bourg El-Arab, 
Alexandria, Egypt. 
Extraction and isolation of compounds 
The isolated fungus Aspergillus versicolor was cultivated on Czapek's peptone liquid medium 
containing (g/l) glucose (30), yeast (2), peptone (10), NaNO3 (3), KH2PO4 (0.5), KCl (0.5), in 50% sea 
water at room temperature. Twenty one-day-old fermentation broth (12 l) was separated from the fungal 
mat by filtration. The fungal mycelia were suspended in distilled water for easy blending by a Ultra 
Turrax model 25 at 8000 min-1 (rpm) and the homogenate was extracted by ethyl acetate. The resultant 
extract was evaporated to dryness using a rotavapor at 40˚C, followed by de-fatting with n-hexane.  
The total extract was suspended in 50% aqueous methanol and partitioned using a modified 
Kupchan’s scheme and then concentrated under reduced pressure. The CH2Cl2 fraction (2.5 g) was 
further fractionated on vacuum liquid chromatography column loaded with silica gel using aCH2Cl2-
MeOH gradient to give four fractions. NMR-guided analysis revealed fraction 2 of interest. Then, Fr 2 
was further purified on Agilent 1200 Infinity semi-preparative HPLC equipped with reversed phase 
column (C18, 250 × 10 mm, L×i.d., Phenomenex Luna) using MeCN in H2O (30-100%) for 30 min 
followed by 100% MeCN for 10 min at 2.0 mL/min flow rate. These conditions afforded 8 compounds 
1 (1.4 mg), 2 (2.2 mg), 3 (1.5 mg), 4 (1.6 mg), 5 (2.2 mg), 6 (2.7 mg), 7 (1.8 mg), and 8 (1.3 mg). 
(-)-Curvularin (1): Colorless powder; [α]D20  -33.5 (c, 0.1, MeOH); 1H NMR (CD3OD, 600 MHz) 
δ (ppm): 6.22 (1H, d, J = 2.5 Hz, H-15), 6.15 (1H, d, J = 2.5 Hz, H-13), 4.89 (1H, m, H-8), 3.83/3.59 
(2H, each, d, J = 5 Hz, H-11), 3.17/2.71 (2H, each, m, H-3), 1.71-1.25 (8H, m, H-4,5,6,7), 1.09 (3H, d, 
J = 6 Hz, 8-CH3); 13C NMR (CD3OD, 150 MHz) δ (ppm): 209.7 (C-2), 172.8 (C-10), 161.2 (C-14), 
159.5 (C-16), 137.2 (C-12), 127.2 (C-1), 112.2 (C-13), 102.7 (C-15), 73.8 (C-8), 44.7 (C-3), 40.5 (C-
11), 33.0 (C-7), 27.7 (C-5), 24.9 (C-6), 23.9 (C-4), 20.5 (8-CH3). HRESIMS: m/z 292.1311, indicting 
the molecular formula C16H20O5 (calculated [M+Na]+ ion for C16H20O5Na at m/z 315.1205). 
Cyclo(L-Pro-L-Ile) (2): White amorphous powder; [α]D20 -78.3 (c, 1.0, MeOH); 1H NMR 
(CD3OD,600 MHz) δ: 4.20 (1H, t J = 8 Hz, Pro-H), 4.08 (1H, dd J = 4.4 Hz Ile-H), 3.56–3.52 (2H, m, 
H-9), 2.32/2.02 (2H, m, H-7), 2.17/1.92 (2H, m, H-8), 1.93 (1H, m, H-10), 1.45/1.32 (2H, m, H-11), 
1.07 (3H, d, J = 6.5 Hz, 14-CH3), 0.93 (3H, d, J = 6.4 Hz 12-CH3). 13C NMR (CDCl3, 150 MHz) δ: 
169.3 (C-5), 165.2 (C-2), 63 (C-3), 58.4 (C-6), 45.7 (C-9), 39.7 (C-10), 29.4 (C-7), 24.5 (C-11), 22 (C-
8), 15.3 (14-CH3), 11.3 (12-CH3). HRESI-MS (m/z 211.1440 [M+H]), calcd. for C11H19N2O2, 
m/z  211.14410. 
Cyclo(L-Tyr-L-Pro) (3); : [α]D20 -69.3 (c, 0.5, MeOH); 1H NMR (CD3OD, 600 MHz) δ: 7.01 (2H, 
d, J = 8 Hz, H-2'/6'), 6.67 (2H, d, J = 8 Hz, H-3'/5'), 3.99 (1H, m, H-3), 3.51 (1H, m, H-6), 3.02 (2H, d, 
J = 6 Hz, H-10), 2.41/2.05 (2H, m, H-9), 1.74 (2H, m, H-7), 1.21 (2H, m, H-8). 13C NMR (CD3OD, 
150 MHz) δ: 170.8 (C-5), 166.9 (C-2), 157.6 (C-4'), 132 (C-2'/6'), 127.7 (C-1'), 116.2 (C-3'/5'), 60.0 
(C-3), 57.7 (C-6), 49.8 (C-9), 37.5 (C-10), 29.3 (C-7), 22.7 (C-8). HRESI-MS (m/z 261.1237 [M+H]), 
calcd. for C14H17N2O3, m/z 261.2960. 
Assay for determination of HCV protease inhibitory activity  
Samples of 2 µl of a compound dissolved in dimethyl sulfoxide (DMSO) were placed in each well of a 
384-well microplate, then 8 µl of recHCV PR (0.5 µg/ml) were added, and the plate was briefly agitated. 
Finally, 10 µl of the freshly prepared substrate [Ac-Asp-Glu-Dap (QXLTM520)-Glu-Glu-Abu-COO-
Ala-Ser-Cys(5-FAMsp)-NH2] were added with sequential rotational shaking. The reaction mixture was 
incubated for 30 min at 37oC. The fluorimetric analyses were performed on an automated TECAN 
GENios plate reader (Männedorf, Switzerland) with excitation wavelength at 485 nm and emission at 
530 nm. Each compound was tested in triplicate. HCV PR inhibition (%) was calculated using the 
following equation [20]: 
% inhibition = (Fsubstrate – Ftest compound) x 100/Fsubstrate 
Where Fsubstrate is the fluorescence of the substrate and enzyme without test compounds, and Ftest compound 
is the fluorescence of the assay mixture with the added compound. 
 
Green protease assay  
The organic extract and active HCV-PR isolated compounds 1-3 were dissolved in DMSO (2.5 µl; final 
content, 10% w/v) and placed in the wells of a 384-well microplate. Then 17.5 µl of assay buffer and 
2.5 µl of trypsin (0.1 U/µl) were added and the plate was briefly agitated. Finally, 2.5 µl of the freshly 
diluted protease substrate HiLyte Fuor TM 488-labeled casein were added under sequential rotary 
shaking and the mixture incubated at 37oC for 30 min. The positive control was the soybean trypsin-
chymotrypsin inhibitor. Inhibition was calculated as for HCV. 
 
Docking study  
Crystal structure of protease enzyme has been downloaded from protein Data bank (PDB ID: 3SV6) 
[22], all water molecules have been removed and native ligand has been deleted for make it ready for 
molecular modelling. Protein has been prepared and compounds has been designed as 3D by VEGA 
ZZ 3.0.5 software, it used also for adjusting the force field of the molecule as AMBER, and atomic 
charge which applied as Gasteiger and energy minimization of them using MOPAC and finally 
outputted as PDBQT. Autodock vina 1.0.3 has been applied for flexible-rigid docking of all molecules 
and Pymol for visualization and studying of hydrogen bonds interaction. 
 
 
Results and Discussion 
The isolated fungus from Red Sea sponge was identified as Aspergillus versicolor based on its 
morphology and authenticated by the molecular analysis of the ITS region of rDNA containing ITS1, 
and ITS4, and the intervening 5.8S rDNA gene. The fungus was grown in a static Czapek's peptone 
liquid medium. The culture broth was extracted with ethyl acetate, and the organic extract was subjected 
to liquid-liquid partitioning and HPLC to yield eight known microbial secondary metabolites (Fig.1) 
related to polyketides as in case of (-)-curvularin (1) and cyclodipeptides or the so called 
diketopiperazines (DKPs) as compounds 2-7.  
Compound 1 to be (-)-curvularin which was first reported from Penicillium sp. [23]. On the other 
hand, the DKPs 2-7 were previously isolated from different microbial sources and identified as cyclo-
(L-Pro-L-Ile), cyclo(L-Tyr-L-Pro), cyclo(L-Phe-L-Pro), cyclo(L-Phe-L-4-hydroxyPro), and cyclo(L-
Try-L-Phe) [24-27]. Compound 7 was deducted based on the HRESI-MS analysis using Antimarin 
database indicated the cyclic tetrapeptidecyclo-[Phenylalanyl-prolyl-leucyl-prolyl] which was 
previously isolated from Pseudoalteromonas sp.[28]. Compound 8 identified as 2-methyl-L-arginine. 
The isolated compounds 1-8 were identified based on their HRESI-MS data and comparison of their 
NMR spectroscopic data and optical rotation data with the reported data. 
 
Biological evaluation 
The ethyl acetate extract of A. versicolor and the isolated compounds 1-8 were evaluated for their in 
vitro antimicrobial activity and anti-HCV protease inhibition. The organic extract and the isolated 
compounds didn't exhibit any antagonistic activities towards the examined microbial pathogens of some 
selected Gram-positive and Gram-negative bacteria as well as Candida albicans and Aspergillus niger 
(fungi). The antimicrobial activity was carried out using the agar diffusion method with 6-mm paper 
disks loaded with 400 and 100 µg of the extract and each pure compound, respectively [29].  
 
 
 
HCV NS3-NS4A protease inhibition  
The ethyl acetate extract of A. versicolor along with compounds 1 - 8 isolated from this extract were 
tested for their inhibitory activity against HCV PR using HCV NS3 protease inhibitor 2 as a positive 
control (Table I). The ethyl acetate extract showed potent activity against HCV NS3-NS4A protease 
with an IC50 value of 30 µg/ml. Isolated diketopiperazines, cyclo-(L-Pro-L-Ile) (2) and cyclo(L-Tyr-L-
Pro) (3) were strongly inhibitory with IC50 values of 13.4  and 8.2 µg/ml, respectively, while (-)-
curvularin (1) was mild inhibitory with an IC50 value of 37.4 µg/ml. The selectivity of the ethyl acetate 
extract and the active compounds 1 - 4 for HCV PR was tested by comparison with their ability to 
inhibit human trypsin. Trypsin is a serine protease similar to HCV PR [30,31]. Cyclo(L-Tyr-L-Pro) (3) 
was more selective as inhibitor of HCV PR as compared to human trypsin with an IC50 value of 37.9 
µg/ml (Table I). These findings suggested that the diketopiprazine 3 selectively inhibited HCV PR with 
highly inhibitory activity and may moderately interfere with human physiological processes requiring 
trypsin activity. It is noteworthy that this is the first report on the inhibition of HCV PR by 
diketopiprazines which warrants further investigation of other members of this widely distributed class 
of compounds. 
 
Docking study  
In order to interpret the results obtained from biological study, docking simulation has been employed 
to give a theoretical imitation of the new discovered compounds binding mode within the protease 
enzyme. This simulation established well the interactions between the HCV PR active site and 
conventional electrophiles such as aldehydes, ketones, α-ketoacids, and α-ketoamides, followed by 
trapping of the resulting covalently bound intermediate by the active site triad, which would provide 
effective inhibition. Additionally, it has been reported that the fitting of ligand functional groups to the 
shallow, solvent-exposed active site of the protease through other forces such as van der Waals, 
aromatic, hydrogen-bonding, and hydrophobic interactions plays an important role in the inhibition of 
the HCV PR [32]. 
Co-crystallized native ligand (Telaprevir) has been used to determine the spatial dimension of grid 
box to include the interactive amino acids; the size has been adjusted relatively larger than the binding 
site. 3D structure of the isolated compound cyclo(L-Tyr-L-Pro) (3) was constructed using VEGA ZZ 
3.0.5 software [33]. Autodock vina 1.0.3 [34] has been used for docking procedures. Pymol software 
[35] has been employed for visualization of mode of interaction. To evaluate the docking tools, native 
ligand has been extracted and re-docked within the enzyme, simulated mode of orientation has shown 
good similarity with co-crystalized one (Fig. 2). Same parameter of re-docking has been applied for the 
docking of the compound. The binding mode of cyclo(L-Tyr-L-Pro) has showed interesting orientation; 
the small molecule 3 has been docked in the deepest part of the exposed binding site. In spite of the 
smaller surface of the cyclo(L-Tyr-L-Pro) compound in comparison with the native ligand, it showed 
surplus of hydrogen bonds interactions with the amino acids backbone of the binding site with 6 
Hydrogen bonds (Fig. 3). 
 
Conclusion 
The ethyl acetate extract from the endophytic fungus Aspergillus versicolor has been established here 
as a source of natural compounds with diverse biological activities, such as anti-HCV-Protease effects. 
The main constituents of the extract were diketopiprazines, which are a group of widely distributed 
natural constituents with diverse pharmacological activities. Thus, we introduce diketopiprazines as 
promising lead HCV PR inhibitors for further semi-synthetic modification aiming at increasing their 
potency and selectivity. 
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Fig. 1: Isolated compounds of A. versicolour  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Fig. 2 
 
 
 
 
 
Fig 2: Co-crystallized native ligand in grey color, and re-docked native ligand in green color. 
 
 
 
 
Fig. 3 
 
 
 
Fig 3: Co-crystallized native ligand in grey color and docked small molecule in white and rose color. 
 
 
 Table 1. Inhibition of HCV NS3-NS4A protease and human trypsin by compounds from A. versicolor 
 
Sample HCV protease inhibitory activity (IC50) 
Trypsin inhibitory activity 
(IC50) 
Ethyl acetate extract 30.00±6.2 >1000 
(1)   37.49±3.6 >1000 
(2)   13.66±3.3 > 1000 
(3) 8.20±1.7      37.9±3.8 
(4) 88.75±4.5 Nt 
(7)   95.32±2.7  Nt  
HCV-I2 1.5 ± 0.5 (1.64 µM) Nt 
T-I Nt 0.01 ± 0.4 (0.5 µM) 
HCV-I2, HCV NS3/4A protease inhibitor 2 (positive control for HCV PR); T-I, soybean trypsin-chymotrypsin inhibitor (positive control for 
trypsin); Nt, not tested.  
 
